In preparation for the Spring Live Meeting of the ACO & Emerging Healthcare Delivery Coalition, 2 speakers who will be at the meeting will participate in 2 30-minute tweetchats.
PLAINSBORO, N.J.—In preparation for the Spring Live Meeting of the ACO & Emerging Healthcare Delivery Coalition, 2 speakers who will be at the meeting will participate in 2 30-minute tweetchats.
The American Journal of Managed Care will host the chats to preview 2 key session taking place during the ACO Coalition live meeting, which is being held April 28-29 in Scottsdale, Arizona.
First, keynote speaker Len Fromer, MD, executive medical director of Group Practice Forum, will answer questions relating to personalized medicine, the triple aim goals, and more on Monday, April 18, 1-1:30 pm ET. His Ywitter handle is @MDWelby.
Then, on Friday, April 22, at 1-1:30 pm ET, AJMC will host a second tweetchat with Patricia Salber, MD, MBA, chief executive officer of The Doctor Weighs In. At the ACO Coalition live meeting, Dr Salber will be sitting on a panel discussion entitled “Focus on 2020: What does the future of healthcare hold?” During the tweetchat, she will answer questions regarding the future of the Affordable Care Act and Medicaid expansion, the longevity of ACOs as a delivery model, and more. Her Twitter handle is @docweighsin.
AJMC encourages Twitter users to submit questions and participate in the chats next week by using #AJMCchat. And don’t forget to follow @AJMC_Journal, @MDWelby, and @docweighsin.
There is still time to register for the ACO Coalition live meeting, held at the JW Marriott Camelback Inn, to see Drs Fromer and Salber live. To view the agenda and for complimentary registration, visit the conference page here.
About the Journals
The American Journal of Managed Care is the leading peer-reviewed journal dedicated to issues in managed care. AJMC.com distributes healthcare news to leading stakeholders across a variety of platforms. Other titles in the franchise include The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
CONTACT: Nicole Beagin (609) 716-7777 x 131
A meta-analysis showed that control group outcomes in psilocybin trials for depression were significantly weaker than those in selective serotonin reuptake inhibitor (SSRI) and esketamine trials, suggesting that psilocybin’s large observed treatment effects may be inflated by methodological factors such as functional unblinding and expectancy bias.
Read More
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
Legal Navigation Services Key to Addressing Disparities in Cancer Care
July 31st 2025A significant number of patients with cancer, caregivers, and health care professionals face significant disparities in legal issues, with the most common needs revolving around health insurance, finances, employment, and disability insurance.
Read More